SYK and autoimmune vasculitis: Up-regulation of SYK has been demonstrated in vitro in murine kidney tissue during early autoimmune vasculitis; therefore, SYK is therefore an attractive therapeutic target for inflammatory diseases, which may include IgAV [59].